间变性淋巴瘤激酶酪氨酸激酶抑制剂布格替尼的药理作用与临床评价
杨雪,倪倩,裴艺芳,封宇飞
Pharmacological and clinical evaluation of brigatinib——an anaplastic lymphoma kinase tyrosine kinase inhibitor
YANG Xue,NI Qian,PEI Yi-fang,FENG Yu-fei
临床药物治疗杂志
.
2018, (6): 32
-36
.
DOI: 10.3969/j.issn.1672-3384.2018.06.009
